Suchergebnisse - "145155-23-3"

PubPharm (148)

1

The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells

enthalten in: Brain research bulletin | 2015

von Damiano, S. | Sasso, A. | De Felice, B. | +9

2

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course : a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs

enthalten in: Clinical immunology (Orlando, Fla.) | 2015

von Gibbs, E. | Karim, M. | Oger, J. | +10

3

Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b : a post hoc analysis of the BEYOND study

enthalten in: European neurology | 2014

von Doerner, M. | Beckmann, K. | Knappertz, V. | +9

4

Interferon β-1b for the treatment of primary progressive multiple sclerosis : five-year clinical trial follow-up

enthalten in: Archives of neurology | 2011

von Tur, C. | Montalban, X. | Tintoré, M. | +11

5

High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS) : a pilot study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2009

von Millonig, A. | Rudzki, D. | Hölzl, M. | +6

6

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b

enthalten in: Expert opinion on biological therapy | 2009

von Durelli, L. | Barbero, P. | Cucci, A. | +65

7

MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients

enthalten in: European journal of neurology | 2008

von Millonig, A. | Dressel, A. | Bahner, D. | +8

8

Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2008

von Sorensen, P. | Koch-Henriksen, N. | Flachs, E. | +1

9

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2008

von Durelli, L. | Barbero, P. | Bergui, M. | +72

CommentIn: J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):616-7. - PMID 18487553

10

Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis

enthalten in: Archives of neurology | 2008

von Sellner, J. | Greeve, I. | Leib, S. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]